| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $0.9B | $0.8B | $0.6B | $0.5B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $0.86 | $1.20 | $1.12 | $0.92 | $0.80 | $0.11 | $0.18 | $0.13 |
| EPS (Diluted) | $0.86 | $1.20 | $1.12 | $0.92 | $0.80 | $0.10 | $0.18 | $0.13 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.6B | $12.6B | $10.9B | $9.3B | $6.8B | $5.0B | $3.6B | $2.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B | $0.2B | $0.1B | $0.2B |
| Total Liabilities | $3.8B | $3.9B | $2.8B | $2.3B | $1.7B | $1.4B | $1.0B | $0.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.5B | $8.3B | $7.8B | $6.6B | $4.8B | $3.2B | $2.6B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.1B | $-1.8B | $-1.7B | $-2.4B | $-1.9B | $-1.0B | $-1.0B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.3B | $1.4B | $1.2B | $2.1B | $1.5B | $0.9B | $0.7B | $0.6B |